Network origin in David S. Arrington first degree
Entity | Entity type | Industry | |
---|---|---|---|
4
| Extinct | Pharmaceuticals: Major | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to David S. Arrington via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
CELGENE | Biotechnology | Corporate Officer/Principal | |
GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
GERON CORPORATION | Biotechnology | Corporate Officer/Principal | |
ALTIGEN COMMUNICATIONS, INC. | Specialty Telecommunications | Director of Finance/CFO | |
Alteon WebSystems, Inc.
Alteon WebSystems, Inc. Telecommunications EquipmentElectronic Technology Alteon WebSystems, Inc. develops, markets, and supports web data products. It also provides networking infrastructure solutions. The company's web data center products include switches, server adapters, and software. Its customers include e-commerce, web portal & web hosting companies, internet service providers, content publishers, server vendors, and enterprises. The company was founded in May 1996 and is headquartered in San Jose, CA. | Telecommunications Equipment | Comptroller/Controller/Auditor | |
Cellerant Therapeutics, Inc.
Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | Medical Specialties | Comptroller/Controller/Auditor | |
AC IMMUNE SA | Pharmaceuticals: Major | Director/Board Member | |
Celgene International SARL
Celgene International SARL Pharmaceuticals: MajorHealth Technology Founded in 2010, Celgene International SARL is a Swiss bio-pharmaceutical company that operates to discover, develop, and commercialize therapies for unmet medical needs in cancer. Part of Bristol Myers Squibb Co., the company is based in Boudry, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Chairman | |
PERSONALIS, INC. | Medical/Nursing Services | Director/Board Member | |
OVID THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal | |
Pomona College
Pomona College Other Consumer ServicesConsumer Services Pomona College offers curriculum in the arts, humanities, social sciences and natural sciences. It was founded in 1887 and it is headquartered in Claremont, CA | College/University | Undergraduate Degree | |
Stanford University | College/University | Doctorate Degree | |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Corporate Officer/Principal | |
Brandeis University | College/University | Undergraduate Degree | |
University of California San Diego | College/University | Graduate Degree | |
The University of Colorado | College/University | Undergraduate Degree | |
VITAE PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
Keck Graduate Institute of Applied Life Sciences | College/University | Director/Board Member | |
National Taiwan University | College/University | Undergraduate Degree | |
SPREADTRUM COMMUNICATIONS, INC (ADR) | Semiconductors | Director of Finance/CFO | |
BioCentury Publications, Inc.
BioCentury Publications, Inc. Publishing: Books/MagazinesConsumer Services BioCentury Publications, Inc. publishes a bioindustry news. It provides information, analysis and data for biotechnology and pharmaceutical companies, investors, academia, and government on the strategic issues essential to the formation, development and sustainability of life science ventures worldwide. The company was founded by David Flores and Karen Bernstein in 1992 and is headquartered in Redwood City, CA. | Publishing: Books/Magazines | Founder | |
Inventages II
Inventages II Investment ManagersFinance Inventages II invests in companies located in Bahamas. The fund focus on companies such as life science and consumer applications. It provides financing for seed, early and buyout capital requirements. | Investment Managers | Founder | |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. BiotechnologyHealth Technology InCarda Therapeutics, Inc. develops cardiovascular disease treatment through pulmonary delivery of established drugs. It also develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. The company was founded by Narasimhan Rangachari, John S. Patton, Gregory M. Marcus and Carlos A. Schuler in 2009 and is headquartered in Newark, CA. | Biotechnology | Director/Board Member | |
Harvard T.H. Chan School of Public Health | College/University | Graduate Degree | |
DIMENSION THERAPEUTICS INC | Biotechnology | Director/Board Member | |
Stanford University School of Medicine | College/University | Doctorate Degree | |
Kellogg School of Management | College/University | Masters Business Admin | |
Human Longevity, Inc.
Human Longevity, Inc. BiotechnologyHealth Technology Human Longevity, Inc. provides precision health analytics to individuals through the Health Nucleus. The Health Nucleus is an assessment of current and future risk for cardiac, oncologic, metabolic and cognitive diseases and conditions. The firm offers database of sequenced genomes and phenotypic data. The company was founded by J. Craig Venter, Robert Joseph Hariri Gordon, and Peter H. Diamandis in 2013 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
KEZAR LIFE SCIENCES, INC. | Biotechnology | Comptroller/Controller/Auditor | |
CODIAK BIOSCIENCES | Pharmaceuticals: Major | Director/Board Member | |
HARPOON THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director/Board Member | |
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Pharmaceuticals: Major | Director/Board Member | |
APPLIED MOLECULAR TRANSPORT INC. | Biotechnology | Corporate Officer/Principal | |
Teon Therapeutics, Inc.
Teon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Teon Therapeutics, Inc. operates as a pharmaceutical company. It focuses on cancer immunotherapy. The company was founded by Yao Lina, Fan Peidong, Elfaith Elzein, and Liiu Jiwen in March 2018 and is headquartered in Redwood City, CA. | Miscellaneous Commercial Services | Director/Board Member | |
ACELYRIN, INC. | Pharmaceuticals: Major | Director/Board Member | |
Anumana, Inc.
Anumana, Inc. Packaged SoftwareTechnology Services Anumana, Inc. is an AI-driven health technology company that leverages cutting-edge AI and industry-leading translational science to unlock the electrical language of the heart. The company is based in Cambridge, MA, and has subsidiaries in the United States. Anumana's software-as-a-medical device (SAMd) solutions aim to detect hidden diseases using ECG-AI algorithms to enhance and improve care through real-time AI insights. The company was founded in 2021 by nference and Mayo Clinic to develop innovative AI technology applied to ECG, electrophysiology, and hemodynamics. The CEO is Murali Aravamudan. | Packaged Software | Director/Board Member | |
Alumis, Inc.
Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a precision medicines company called Esker that aims to provide personalized treatments for people with autoimmune diseases. The company is based in San Francisco, CA. Esker uses a precision analytics platform, powered by foresite labs, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology to create medicines that change the lives of people with autoimmune disease. The company was founded by June H Lee. Martin Babler has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
EFFECTOR THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Solve Therapeutics, Inc.
Solve Therapeutics, Inc. BiotechnologyHealth Technology Solve Therapeutics, Inc. is an oncology-focused biopharmaceutical company that develops novel antibody-based therapies targeting tumor-specific antigens. The company is based in Belmont, CA, and has subsidiaries in the United States. The company's formation has reunited members of the former VelosBio Inc. team, a highly experienced group with a proven ability to rapidly advance innovative therapeutics that address unmet medical needs in the treatment of cancer. Solvetx has been actively pursuing discovery and development efforts at its state-of-the-art laboratory facilities. The company has licensed or generated targeting antibodies and nanobodies with ideal characteristics to serve as the backbones for antibody-based therapeutics and has rights to technology supporting the development of diagnostic and therapeutic antibody-radionuclide conjugates (ARCs). Solvetx is supported by a syndicate of sophisticated healthcare investors, including Ayurmaya Capital Management Fund (an affiliate of Matrix Capital Management), Decheng Capital, General, and Surveyor Capital (a Citadel company). The company was founded by David M. Johnson and has been led by him as the CEO since incorporation. | Biotechnology | Director/Board Member |
Statistics
International
United States | 46 |
Switzerland | 4 |
Taiwan | 2 |
Cayman Islands | 2 |
Sectoral
Health Technology | 28 |
Consumer Services | 14 |
Finance | 4 |
Electronic Technology | 3 |
Commercial Services | 3 |
Operational
Director/Board Member | 23 |
Independent Dir/Board Member | 12 |
Corporate Officer/Principal | 10 |
Comptroller/Controller/Auditor | 5 |
Undergraduate Degree | 4 |
Most connected contacts
Insiders | |
---|---|
Alan Colowick | 30 |
Karen Bernstein | 9 |
Elizabeth Bhatt | 9 |
Pattie Chiang | 7 |
- Stock Market
- Insiders
- David S. Arrington
- Company connections